Cantel Medical Corp. (CMD) financial statements (2022 and earlier)

Company profile

Business Address OVERLOOK AT GREAT NOTCH
LITTLE FALLS, NJ 07424
State of Incorp. DE
Fiscal Year End July 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

4/30/2021
Q3
1/31/2021
Q2
10/31/2020
Q1
7/31/2020
Q4
4/30/2020
Q3
1/31/2020
Q2
10/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2192432582781165949
Cash and cash equivalents2192432582781165949
Receivables204203186182163169175
Inventory, net of allowances, customer advances and progress billings179170164168185184200
Inventory179170164168185184200
Other undisclosed current assets24221918222625
Total current assets:626638627647486438450
Noncurrent Assets
Finance lease, right-of-use asset4444555
Operating lease, right-of-use asset45464444454747
Property, plant and equipment228226224225224230228
Intangible assets, net (including goodwill)1,1211,1291,1321,1401,1401,1531,162
Goodwill666666660660654657655
Intangible assets, net (excluding goodwill)455463471480486497507
Deferred income tax assets  45574
Other noncurrent assets876671110
Total noncurrent assets:1,4051,4121,4131,4251,4261,4531,456
TOTAL ASSETS:2,0312,0502,0412,0721,9121,8911,906
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities172172147136129113122
Accounts payable59544742533840
Accrued liabilities57574641383741
Employee-related liabilities51554848333736
Taxes payable6674625
Deferred revenue31302826272627
Debt3023158424034
Other undisclosed current liabilities10101010 25 
Total current liabilities:243235200179198204183
Noncurrent Liabilities
Long-term debt and lease obligation773831885968986929919
Long-term debt, excluding current maturities732788845927944885876
Finance lease, liability4444444
Operating lease, liability37383637373939
Liabilities, other than long-term debt68697171403537
Deferred revenue0010  0
Deferred income tax liabilities51505050282931
Other liabilities172020211356
Other undisclosed noncurrent liabilities130128126125  35
Total noncurrent liabilities:9711,0281,0821,1631,026964990
Total liabilities:1,2141,2631,2821,3421,2241,1681,174
Stockholders' equity
Stockholders' equity attributable to parent817788758730688723732
Common stock5555555
Treasury stock, value(71)(71)(70)(69)(69)(68)(68)
Additional paid in capital285282276273241266268
Accumulated other comprehensive loss(7)(12)(25)(28)(42)(17)(17)
Retained earnings606585573548554538545
Total stockholders' equity:817788758730688723732
TOTAL LIABILITIES AND EQUITY:2,0312,0502,0412,0721,9121,8911,906

Income statement (P&L) ($ in millions)

4/30/2021
Q3
1/31/2021
Q2
10/31/2020
Q1
7/31/2020
Q4
4/30/2020
Q3
1/31/2020
Q2
10/31/2019
Q1
Revenues314294297233237288257
Cost of revenue
(Cost of Goods and Services Sold)
(163)(151)(150)(136)(136)(166)(141)
Gross profit:15114314797101122116
Operating expenses(106)(112)(97)(93)(79)(115)(101)
Operating income:463250422814
Interest and debt expense(15)(15)(16)25(10)(10)(6)
Income (loss) from continuing operations before equity method investments, income taxes:3116342912(3)9
Other undisclosed loss from continuing operations before income taxes   (40)   
Income (loss) from continuing operations before income taxes:311634(11)12(3)9
Income tax expense (benefit)(10)(4)(10)630(3)
Net income (loss) attributable to parent:211224(6)16(2)6
Undistributed earnings (loss) allocated to participating securities, basic   0  (0)
Net income (loss) available to common stockholders, diluted:211224(6)16(2)6

Comprehensive Income ($ in millions)

4/30/2021
Q3
1/31/2021
Q2
10/31/2020
Q1
7/31/2020
Q4
4/30/2020
Q3
1/31/2020
Q2
10/31/2019
Q1
Net income (loss):211224(6)16(2)6
Comprehensive income (loss):211224(6)16(2)6
Other undisclosed comprehensive income (loss), net of tax, attributable to parent513214(25)05
Comprehensive income (loss), net of tax, attributable to parent:2625279(9)(2)11

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: